Biogen
In Mason Hawkins's portfolio · Longleaf Partners
Ticker BIIB
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Longleaf Partners 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2022 | Sell | 0 | |
| Q1 2022 | Reduce 2% | 842,962 | 3.1% |
| Q4 2021 | Buy | 858,523 | 3.5% |
| Q2 2021 | Sell | 0 | |
| Q1 2021 | Buy | 603,890 | 3.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.